The synthesis of 11-substituted 6-amino-11,12-dihydrobenzo[c]phenanthridines and 11-substituted 6-aminobenzo[c]phenanthridines through an efficient method is described. The antiproliferative activity of selected compounds against a wide panel of tumor cell lines was tested in the in vitro anticancer screening and the in vivo hollow fiber assay of the National Cancer Institute. Several compounds turned out to exhibit considerable cytotoxicity for tumor cells. For the study of structure-activity relationships different substituents were introduced in the 11-position. Compounds with methoxyphenyl substituents tended to show the highest potency. Several compounds exhibited noteworthy antitumor activity with GI(50) values across all cell lines <1 microM. 6-Amino-11-(3,4,5-trimethoxyphenyl)benzo[c]phenanthridine perchlorate was the most potent agent in the NCI's in vivo hollow fiber assay. Most of the tested compounds showed a remarkable selectivity for leukemia, breast cancer, and prostate cancer.
Fused pyridine derivatives R 0450 A Two-Step Synthesis of Cytostatically Active Benzo[c]phenanthridine Derivatives. -With exception of paclitaxel, title compounds (IIIc) and (VI) exhibit higher cytostatic activities than established cytostatics like cyclophosphamide or fagaronine. -(CLEMENT*, B.; WEIDE, M.; WOLSCHENDORF, U.; KOCK, I.; Angew. Chem., Int. Ed. 44 (2005) 4, 635-638; Pharm. Inst., Christian-Albrechts-Univ.,
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.